Modalis Therapeutics Corporation announced consolidated earnings results for the Fiscal Year Ended December 31, 2020. For the period, the company reported operating revenue of JPY 342 million against JPY 644 million a year ago. Operating loss was JPY 398 million against operating income of JPY 157 million a year ago. Loss was JPY 448 million against profit of JPY 140 million a year ago. Net loss per share was JPY 17.02 against net income of JPY 5.96 per share a year ago.